By Professor Wayne Denis Hall

Journal articles

Teesson M; Hall WD; Lynskey MT; Degenhardt LJ, 2000, 'Alcohol- and drug-use disorders in Australia: Implications of the National Survey of Mental Health and wellbeing', Australian and New Zealand Journal of Psychiatry, pp. 206 - 213

Henderson S; Andrews JG; Hall WD, 2000, 'Australia`s mental health: an overview of the general population survey', Australian and New Zealand Journal of Psychiatry, pp. 197 - 205

Hall WD; Degenhardt LJ, 2000, 'Cannabis use and psychosis: A review of clinical and epidemiological evidence', Australian and New Zealand Journal of Psychiatry, pp. 26 - 34

Hall WD; Babor TF, 2000, 'Cannabis use and public health: Assessing the burden', Addiction, pp. 485 - 490

Hall WD; Zador D, 2000, 'Challenge of reducing drug-related deaths', Lancet, pp. 7 - 8

Darke S; Hall WD; Kaye SS; Ross JE, 2000, 'Hair morphine concentrations of fatal heroin overdose cases and living heroin users', Addiction, 97, pp. 977 - 984

Strang J; Witton J; Hall WD, 2000, 'Improving the quality of the cannabis debate: Defining the different domains', British Medical Journal: Clinical Research, pp. 108 - 110

Hall WD; Mattick RP, 2000, 'Is ultra-rapid detoxification a viable option in the treatment of opioid dependence', CNS Drugs, 14, pp. 251 - 255

Bryant RA; Harvey AG, 2000, 'Letter to the editor', American Journal of Psychiatry, 157, pp. 1889 - 1890

Boot B; Mcgregor I; Hall WD, 2000, 'MDMA (Ecstasy) neurotoxicity: Assessing and communicating the risks', Lancet, pp. 1818 - 1821

Swift W; Hall WD; Copeland J, 2000, 'One year follow-up of cannabis dependence among long-term users in Sydney, Australia', Drug and Alcohol Dependence, pp. 309 - 318

Hall WD, 2000, 'Rolleston revisted', Addiction, pp. 1273 - 1274

Hall WD; Lynskey MT, 2000, 'The effects of adolescent cannabis use on education attainment: A review', Addiction, pp. 1621 - 1630

Hall WD; Swift W, 2000, 'The THC content of cannabis in Australia: Evidence and implications', Australian and New Zealand Journal of Public Health, pp. 503 - 508

Hall WD, 2000, 'Transcending methadone', Lancet, pp. 585

Hall W, 2000, 'Transcending methadone', The Lancet, 355, pp. 585 - 585, http://dx.doi.org/10.1016/s0140-6736(05)73246-3

Hall WD; Lynskey MT; Degenhardt LJ, 2000, 'Trends in opiate-related deaths in the United Kingdom and Australia, 1985-1995', Drug and Alcohol Dependence, pp. 247 - 254

Hall WD, 2000, 'UROD: an Antipodean therapeutic enthusiasm', Addiction, pp. 1765

Lynskey M; Hall W, 1999, 'A reply to Caplehorn', DRUG AND ALCOHOL REVIEW, 18, pp. 488 - 488, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000084905300013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hall WD, 1999, 'Representation of blacks, women, and the very elderly (aged ≥80) in 28 major randomized clinical trials', Ethnicity and Disease, 9, pp. 333 - 340

Hall WD; Degenhardt LJ; Lynskey MT, 1999, 'Opioid overdose mortality in Australia, 1964-1997: Birth-cohort trends', Medical Journal of Australia, 171, pp. 34 - 37, http://dx.doi.org/10.5694/j.1326-5377.1999.tb123495.x

Hall WD, 1999, 'A rational approach to the treatment of hypertension in special populations', American Family Physician, 60, pp. 156 - 162

Coates RJ; Bowen DJ; Kristal AR; Feng Z; Oberman A; Hall WD; George V; Lewis CE; Kestin M; Davis M; Evans M; Grizzle JE; Clifford CK, 1999, 'The Women's Health Trial Feasibility Study in Minority Populations: Changes in dietary intakes', American Journal of Epidemiology, 149, pp. 1104 - 1112, http://dx.doi.org/10.1093/oxfordjournals.aje.a009764

Hall W, 1999, 'Reducing the toll of opioid overdose deaths in Australia', Drug and Alcohol Review, 18, pp. 213 - 220, http://dx.doi.org/10.1080/09595239996662

Darke S; Hall W; Weatherburn D; Lind B, 1999, 'Fluctuations in heroin purity and the incidence of fatal heroin overdose', Drug and Alcohol Dependence, 54, pp. 155 - 161, http://dx.doi.org/10.1016/S0376-8716(98)00159-8

Hall W, 1999, 'Patient matching in treatment for alcohol dependence: Is the null hypothesis still alive and well?', Addiction, 94, pp. 52 - 54

Prisant LM; Neutel JM; Ferdinand K; Papademetriou V; DeQuattro V; Hall WD; Weir MR, 1999, 'Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks', Journal of the National Medical Association, 91, pp. 40 - 48

Hall WD, 1999, 'NSAIDs and renal function in older people', Journal of the American Geriatrics Society, 47, pp. 626, http://dx.doi.org/10.1111/j.1532-5415.1999.tb02580.x

Hall WD, 1999, 'Risk reduction associated with lowering systolic blood pressure: Review of clinical trial data', American Heart Journal, 138, pp. S225 - S230, http://dx.doi.org/10.1016/s0002-8703(99)70314-5

Hall WD, 1999, 'Confronting the forbidden: drug addiction', Lancet, pp. 1395

Hall W, 1999, 'Confronting the forbidden: drug addiction', The Lancet, 354, pp. 1395 - 1395, http://dx.doi.org/10.1016/s0140-6736(05)76254-1

Dolan K; Wodak AD; Hall WD, 1999, 'HIV risk behaviour and prevention in prison: a bleach programme for inamtes in NSW', Drug and Alcohol Review, 18, pp. 139 - 143

Hall WD; Wodak AD, 1999, 'Is naltrexone a cure for heroin dependence?', Medical Journal of Australia, 171, pp. 9 - 10

Hall WD; Degenhardt LJ; Lynskey MT, 1999, 'Opioid overdose mortality in Australia, 1964-1997', Medical Journal of Australia, 171, pp. 34 - 37

Hall W, 1999, 'Opium in Britain: conflicting and converging interests', The Lancet, 353, pp. 1449 - 1449, http://dx.doi.org/10.1016/s0140-6736(99)00075-6

Bolin TD; Korman M; Stanton R; Talley NJ; Newstead GL; Donnelly N; Hall WD; Ho MT; Lapsley HM, 1999, 'Positive cost effectiveness of early diagnosis of colorectal cancer', Colorectal Disease, 1, pp. 113 - 122

Lynskey MT; White V; Hill D; Letcher T; Hall WD, 1999, 'Prevalence of illicit drug use among youth: results from the Australian School Students` Alcohol and Drugs Survey', Australian and New Zealand Journal of Public Health, pp. 519 - 524

Hall WD, 1999, 'Reducing the toll of opioid overdose deaths in Australia', Drug and Alcohol Review, 18, pp. 219 - 226

Ward JB; Hall WD; Mattick RP, 1999, 'Role of maintenance treatment in opioid dependence', Lancet, pp. 221

Hall WD; Teesson M; Lynskey MT; Degenhardt LJ, 1999, 'The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-Being', Addiction, pp. 1541 - 1550

Hall W; Room R, 1998, 'High anxieties', New Scientist, 158, pp. 55

Martin BR; Hall W, 1998, 'The health effects of cannabis: Key issues of policy relevance', Bulletin on Narcotics, 50, pp. 85 - 116

Hall WD; Montoro R; Littlejohn T; Jain A; Feliciano N; Zheng H, 1998, 'Efficacy and tolerability of valsartan in combination with hydrochlorothiazide in essential hypertension', Clinical Drug Investigation, 16, pp. 203 - 210, http://dx.doi.org/10.2165/00044011-199816030-00004

Hall W, 1998, 'The respiratory risks of cannabis smoking', Addiction, 93, pp. 1461 - 1463, http://dx.doi.org/10.1080/09652149834586

Hall WD; Reed JW; Flack JM; Yunis C; Preisser J, 1998, 'Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension', Archives of Internal Medicine, 158, pp. 2029 - 2034, http://dx.doi.org/10.1001/archinte.158.18.2029

Venning GR; Wodak A; Hall W; Farrell M, 1998, 'The Swiss heroin trials', BMJ, 317, pp. 1011, http://dx.doi.org/10.1136/bmj.317.7164.1011

Venning GR; Wodak A; Hall W; Farrell M, 1998, 'The Swiss heroin trials (multiple letters) [1]', British Medical Journal, 317, pp. 1011 - 1012

Hall WD, 1998, 'A perspective on the calcium antagonists in blacks (CAB) trial.', Ethnicity Disease, 8, pp. 296 - 298

Farrell M; Hall W, 1998, 'The Swiss heroin trials: Testing alternative approaches', British Medical Journal, 316, pp. 639, http://dx.doi.org/10.1136/bmj.316.7132.639

Prisant LM; Neutel JM; Papademetriou V; DeQuattro V; Hall WD; Weir MR, 1998, 'Low-dose combination treatment for hypertension versus single-drug treatment - Bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: Combined analysis of comparative studies', American Journal of Therapeutics, 5, pp. 313 - 321, http://dx.doi.org/10.1097/00045391-199809000-00007

Back to profile page